N P Peet

Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.

J. A. Malikayil, H. Schreuder, C. Tardif, 1997, Biochemistry.

A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors.

N P Peet, H J Weintraub, N L Lentz, 1990, Journal of medicinal chemistry.

Novel time-dependent inhibitors of human placental aromatase.

J P Burkhart, N P Peet, C L Wright, 1991, Journal of medicinal chemistry.

Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.

H. Schreuder, C. Tardif, N. Peet, 1998, Journal of medicinal chemistry.

Synthesis and antiallergic activity of some quinolinones and imidazoquinolinones.

N. Peet, N P Peet, S. Sunder, 1985, Journal of medicinal chemistry.

Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717.

A. Bitonti, J. Dumont, P. Wright, 2001, Journal of medicinal chemistry.